Glial cell line-derived neurotrophic factor is increased in cerebrospinal fluid but decreased in blood during long-term pain

Journal of Neuroimmunology

Volumn 220, Issue 1-2, 2010, Pages 108-113

  Lundborg, Christopher ^a   Hahn Zoric, Mirjana ^b   Biber, Björn ^a   Hansson, Elisabeth ^b  

^a SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; Cytokines; Glial cell line derived neurotrophic factor; Inflammation; Osteoarthritis; Pain

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HUMAN; INFLAMMATION; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CHEMOKINES; CHRONIC DISEASE; CYTOKINES; DISABILITY EVALUATION; DOWN-REGULATION; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN MEASUREMENT; PAIN, INTRACTABLE; PERIPHERAL NERVOUS SYSTEM; UP-REGULATION;

EID: 77649182701     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.01.007     Document Type: Article

References (55)

1. Airaksinen M.S., and Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3 (2002) 383-394
2. Albers K.M., Woodbury C.J., Ritter A.M., Davis B.M., and Koerber H.R. Glial cell-line-derived neurotrophic factor expression in skin alters the mechanical sensitivity of cutaneous nociceptors. J. Neurosci. 26 (2006) 2981-2990
3. Alexander G.M., Van Rijn M.A., Van Hilten J.J., Perreault M.J., and Schwartzman R.J. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 116 (2005) 213-219
4. Amaya F., Shimosato G., Nagano M., Ueda M., Hashimoto S., Tanaka Y., Suzuki H., and Tanaka M. NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia. Eur. J. NeuroSci. 20 (2004) 2303-2310
5. Apfel S.C. Neurotrophic factors in peripheral neuropathies: therapeutic implications. Brain Pathol. 9 (1999) 393-413
6. Appel E., Kolman O., Kazimirsky G., Blumberg P.M., and Brodie C. Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. NeuroReport 8 (1997) 3309-3312
7. Backonja M.M., Coe C.L., Muller D.A., and Schell K. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J. Neuroimmunol. 195 (2008) 157-163
8. Boucher T.J., and Mcmahon S.B. Neurotrophic factors and neuropathic pain. Curr. Opin. Pharmacol. 1 (2001) 66-72
9. Boucher T.J., Okuse K., Bennett D.L., Munson J.B., Wood J.N., and Mcmahon S.B. Potent analgesic effects of GDNF in neuropathic pain states. Science 290 (2000) 124-127
10. Brisby H., Olmarker K., Larsson K., Nutu M., and Rydevik B. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur. Spine J. 11 (2002) 62-66
11. Chiaretti A., Piastra M., Polidori G., Di Rocco C., Caresta E., Antonelli A., Amendola T., and Aloe L. Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury. Intensive Care Med. 29 (2003) 1329-1338
12. Chiaretti A., Antonelli A., Piastra M., Genovese O., Polidori G., and Aloe L. Expression of neurotrophic factors in cerebrospinal fluid and plasma of children with viral and bacterial meningoencephalitis. Acta Paediatr. 93 (2004) 1178-1184
13. Ciobanu C., Reid G., and Babes A. Acute and chronic effects of neurotrophic factors BDNF and GDNF on responses mediated by thermo-sensitive TRP channels in cultured rat dorsal root ganglion neurons. Brain Res. 1284 (2009) 54-67
14. De Ceuninck F., Dassencourt L., and Anract P. The inflammatory side of human chondrocytes unveiled by antibody microarrays. Biochem. Biophys. Res. Commun. 323 (2004) 960-969
15. Deleo J.A., Tanga F.Y., and Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 10 (2004) 40-52
16. Empl M., Renaud S., Erne B., Fuhr P., Straube A., Schaeren-Wiemers N., and Steck A.J. TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56 (2001) 1371-1377
17. Fang M., Wang Y., He Q.H., Sun Y.X., Deng L.B., Wang X.M., and Han J.S. Glial cell line-derived neurotrophic factor contributes to delayed inflammatory hyperalgesia in adjuvant rat pain model. Neuroscience 117 (2003) 503-512
18. Grundstrom E., Lindholm D., Johansson A., Blennow K., and Askmark H. GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis. NeuroReport 11 (2000) 1781-1783
19. Gur A., Karakoc M., Nas K., Remzi C., Denli A., and Sarac J. Cytokines and depression in cases with fibromyalgia. J. Rheumatol. 29 (2002) 358-361
20. Hao S., Mata M., Wolfe D., Huang S., Glorioso J.C., and Fink D.J. HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Mol. Ther. 8 (2003) 367-375
21. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simmons L., Moffet B., Vandlen R.A., Simpson L.C., et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266 (1994) 1062-1064
22. Huber J.D., Witt K.A., Hom S., Egleton R.D., Mark K.S., and Davis T.P. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H1241-H1248
23. Iwahashi N., Murakami H., Nimura Y., and Takahashi M. Activation of RET tyrosine kinase regulates interleukin-8 production by multiple signaling pathways. Biochem. Biophys. Res. Commun. 294 (2002) 642-649
24. Johnston I.N., Milligan E.D., Wieseler-Frank J., Frank M.G., Zapata V., Campisi J., Langer S., Martin D., Green P., Fleshner M., Leinwand L., Maier S.F., and Watkins L.R. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci. 24 (2004) 7353-7365
25. Kastin A.J., Akerstrom V., and Pan W. Glial cell line-derived neurotrophic factor does not enter normal mouse brain. Neurosci. Lett. 340 (2003) 239-241
26. Koch A., Zacharowski K., Boehm O., Stevens M., Lipfert P., Von Giesen H.J., Wolf A., and Freynhagen R. Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm. Res. 56 (2007) 32-37
27. Kotani N., Kudo R., Sakurai Y., Sawamura D., Sessler D.I., Okada H., Nakayama H., Yamagata T., Yasujima M., and Matsuki A. Cerebrospinal fluid interleukin 8 concentrations and the subsequent development of postherpetic neuralgia. Am. J. Med. 116 (2004) 318-324
28. Leffler A., Cummins T.R., Dib-Hajj S.D., Hormuzdiar W.N., Black J.A., and Waxman S.G. GDNF and NGF reverse changes in repriming of TTX-sensitive Na(+) currents following axotomy of dorsal root ganglion neurons. J. Neurophysiol. 88 (2002) 650-658
29. Ludwig J., Binder A., Steinmann J., Wasner G., and Baron R. Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies. J. Neurol. Neurosurg. Psychiatry 79 (2008) 1268-1273
30. Malin S.A., Molliver D.C., Koerber H.R., Cornuet P., Frye R., Albers K.M., and Davis B.M. Glial cell line-derived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. J. Neurosci. 26 (2006) 8588-8599
31. Meller S.T., Dykstra C., Grzybycki D., Murphy S., and Gebhart G.F. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33 (1994) 1471-1478
32. Milligan E.D., Mehmert K.K., Hinde J.L., Harvey L.O., Martin D., Tracey K.J., Maier S.F., and Watkins L.R. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 861 (2000) 105-116
33. Milligan E.D., Twining C., Chacur M., Biedenkapp J., O'connor K., Poole S., Tracey K., Martin D., Maier S.F., and Watkins L.R. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 23 (2003) 1026-1040
34. Nagano M., Sakai A., Takahashi N., Umino M., Yoshioka K., and Suzuki H. Decreased expression of glial cell line-derived neurotrophic factor signaling in rat models of neuropathic pain. Br. J. Pharmacol. 140 (2003) 1252-1260
35. Ogun-Muyiwa P., Helliwell R., Mcintyre P., and Winter J. Glial cell line derived neurotrophic factor (GDNF) regulates VR1 and substance P in cultured sensory neurons. NeuroReport 10 (1999) 2107-2111
36. Oppenheim R.W., Houenou L.J., Johnson J.E., Lin L.F., Li L., Lo A.C., Newsome A.L., Prevette D.M., and Wang S. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373 (1995) 344-346
37. Petty M.A., and Lo E.H. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 68 (2002) 311-323
38. Rosa A.R., Frey B.N., Andreazza A.C., Cereser K.M., Cunha A.B., Quevedo J., Santin A., Gottfried C., Goncalves C.A., Vieta E., and Kapczinski F. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci. Lett. 407 (2006) 146-150
39. Rozen T., and Swidan S.Z. Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 47 (2007) 1050-1055
40. Sarchielli P., Alberti A., Candeliere A., Floridi A., Capocchi G., and Calabresi P. Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia. Cephalalgia 26 (2006) 409-415
41. Schmutzler B.S., Roy S., and Hingtgen C.M. Glial cell line-derived neurotrophic factor family ligands enhance capsaicin-stimulated release of calcitonin gene-related peptide from sensory neurons. Neuroscience 161 (2009) 148-156
42. Suter-Crazzolara C., and Unsicker K. GDNF is expressed in two forms in many tissues outside the CNS. NeuroReport 5 (1994) 2486-2488
43. Takebayashi M., Hisaoka K., Nishida A., Tsuchioka M., Miyoshi I., Kozuru T., Hikasa S., Okamoto Y., Shinno H., Morinobu S., and Yamawaki S. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int. J. Neuropsychopharmacol. 9 (2006) 607-612
44. Trupp M., Ryden M., Jornvall H., Funakoshi H., Timmusk T., Arenas E., and Ibanez C.F. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130 (1995) 137-148
45. Tu H., Juelich T., Smith E.M., Tyring S.K., Rady P.L., and Hughes Jr. T.K. Evidence for endogenous interleukin-10 during nociception. J. Neuroimmunol. 139 (2003) 145-149
46. Uceyler N., Valenza R., Stock M., Schedel R., Sprotte G., and Sommer C. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum. 54 (2006) 2656-2664
47. Vellani V., Zachrisson O., and Mcnaughton P.A. Functional bradykinin B1 receptors are expressed in nociceptive neurones and are upregulated by the neurotrophin GDNF. J. Physiol. 560 (2004) 391-401
48. Wang H., Moser M., Schiltenwolf M., and Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia - a prospective longitudinal study over 6 months. J. Rheumatol. 35 (2008) 1366-1370
49. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30 (1992) 473-483
50. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discov. 2 (2003) 973-985
51. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., and Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654 (1994) 15-26
52. Watkins L.R., Maier S.F., and Goehler L.E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63 (1995) 289-302
53. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 24 (2001) 450-455
54. Wieseler-Frank J., Maier S.F., and Watkins L.R. Central proinflammatory cytokines and pain enhancement. Neurosignals 14 (2005) 166-174
55. Woolf C.J., and Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 288 (2000) 1765-1769